Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mukta Shiwalkar"'
Autor:
Stephanie Grauer, Chadwick King, Jilin Sun, Steven J. Swanson, Troy E. Barger, Daniel T. Mytych, Andrew J. Kuck, Mukta Shiwalkar, Raj Haldankar, Eric Hsu, Sergio Sanchez, Francesca Civoli, Michelle Wu
Publikováno v:
Journal of Immunological Methods. 382:129-141
Recombinant human erythropoietin (EPO) has been used therapeutically for more than two decades in the treatment of anemia. Although EPO is generally well tolerated, in rare cases, patients have developed anti-EPO antibodies that can negatively impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a9f05686c7647abefe186ded83cd17b
https://doi.org/10.1016/j.jim.2012.05.013
https://doi.org/10.1016/j.jim.2012.05.013
Autor:
Peng Yang, Alla Verlinsky, Christopher Kemball, Claudia Guevara, Mukta Shiwalkar, Daniel S. Pereira, Sung-Ju Moon, Dowdy Jacksosn, Cyrus Virata, David R. Stover, Ssucheng J. Hsu, Min Michelle Wu, Ingrid B.J.K. Joseph, Nandini Rudra-Ganguly, William Yeh, Christine Lowe, Michael D. Mattie
Publikováno v:
Cancer Research. 74:1976-1976
Multidrug resistance may play a critical role in developing cancer therapeutics for acute leukemia. The expression of the ATP binding cassette (ABC) transporter Pgp/MDR1 (also known as ABCB1) has been reported in AML patients and correlates with poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b9609fdac7971199b9b97c4f1cec351
https://doi.org/10.1158/1538-7445.am2014-1976
https://doi.org/10.1158/1538-7445.am2014-1976